1,1'-Carbonyldiimidazole → methyl 2-((R)-(3-fluorophenyl)((3R)-1-((S)-1-(N-Methyl-2-(trimethylsilyl)ethoxycarbonylamino)-3-(tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate
Reaction equation
[NH2:1][C@@H:2]([CH2:15][CH:16]1[CH2:21][CH2:20][CH2:19][O:18][CH2:17]1)[CH2:3][N:4]([CH3:14])[C:5](=[O:13])[O:6][CH2:7][CH2:8][Si:9]([CH3:12])([CH3:11])[CH3:10].C1N=CN([C:27]([N:29]2[CH:33]=N[CH:31]=[CH:30]2)=[O:28])C=1.CCN(C(C)C)C(C)C.[CH3:43][O:44][C:45](=[O:64])[NH:46][CH2:47][CH2:48][O:49][CH:50]([C:57]1[CH:62]=[CH:61][CH:60]=[C:59]([F:63])[CH:58]=1)[CH:51]1CCCN[CH2:52]1>C(Cl)Cl>[F:63][C:59]1[CH:58]=[C:57]([C@@H:50]([C@@H:51]2[CH2:52][CH2:31][CH2:30][N:29]([C:27](=[O:28])[NH:1][C@@H:2]([CH2:15][CH:16]3[CH2:21][CH2:20][CH2:19][O:18][CH2:17]3)[CH2:3][N:4]([C:5]([O:6][CH2:7][CH2:8][Si:9]([CH3:12])([CH3:11])[CH3:10])=[O:13])[CH3:14])[CH2:33]2)[O:49][CH2:48][CH2:47][NH:46][C:45](=[O:64])[O:44][CH3:43])[CH:62]=[CH:61][CH:60]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
To a solution of 2-(trimethylsilyl)ethyl (S)-2-amino-3-(tetrahydro-2H-pyran-3-yl)propyl(methyl)carbamate (300 mg, 0.95 mmol) and CDI (154 mg, 0.95 mmol) in anhydrous CH2Cl2 (20 mL), DIEA (612 mg, 4.7 mmol) was added with ice bath. After addition, the mixture was stirred for 1 h at 0° C., then was added to a solution of {2-[(3-fluoro-phenyl)-piperidin-3-yl-methoxy]-ethyl}-carbamic acid methyl ester (245 mg, 0.79 mmol) in anhydrous CH2Cl2 (25 mL). The reaction mixture was allowed to warm to rt and stirred overnight. After the reaction was completed, the solvent was removed in vacuo. The product was purified by preparative TLC to afford methyl 2-((R)-(3-fluorophenyl)((3R)-1-((S)-1-(N-Methyl-2-(trimethylsilyl)ethoxycarbonylamino)-3-(tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate (258 mg, 50% yield).
Workup
- additionAfter addition
- temperatureto warm to rt
- stirringstirred overnight
- customthe solvent was removed in vacuo
- customThe product was purified by preparative TLC
Sources & evidence
- ORD record
- ord-d56fe6c0cd0842a4bb343eaf5e3fe4d3
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08487108B2
Reaction notes
Loading…